Site icon Hot Paths

Telesis Bio secures up to $21M to accelerate adoption of Gibson SOLA

  • Telesis Bio (OTC:TBIO) has entered into a convertible preferred stock purchase agreement to sell shares of a new series of convertible preferred stock in a private placement for gross proceeds of up to around $21M.
  • The purchase agreement provides for
Exit mobile version